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Abstract 
Background: In previous studies we found mild deficiencies of circulating T cells in patients with bipolar disorder 
(BD) and children at risk for BD, correlating to a higher inflammatory state. The genetic and environmental influences 
on these T cell deficiencies in association with BD development are unknown.
Objectives: The aim is to quantify genetic and environmental factors that contribute to the association between the 
liability to develop BD and T cell deficiencies.
Methods: Participants of a Dutch bipolar twin study (11 monozygotic BD twin pairs, 15 dizygotic BD twin pairs, 15 
monozygotic and 12 dizygotic healthy twin pairs) were included. A detailed FACS analysis of frozen stored leukocytes 
was carried out to determine the percentages of T cells and various other leukocyte and lymphocyte subsets. A bivari-
ate liability threshold twin model was used to determine genetic and environmental (common and unique) influ-
ences on the correlation between BD and the various subsets.
Results: Lower percentages of T cells and higher percentages of NK cells were associated with the familial liability to 
develop BD. Neither genetic nor shared or unique environmental factors could explain the associations. Lithium usage 
explained part of the association for T cells, smoking in part that for NK cells.
Conclusions: Our results confirm that BD is the result of a complex interaction between various genetic and environ-
mental risk factors, in which T and NK cells act as important intermediate immune players.
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Introduction
The origin of bipolar disorder (BD) has a multitude of 
factors, both genetic influences and environmental fac-
tors play a role in the pathogenesis. Chronic low grade 
inflammation is presently thought to play an important 
role as one of such factors, in at least part of the patients. 
In a previous twin study we showed that a, not yet iden-
tified, common environmental factor, shared between 
twins, dominates the association between BD and the 
raised level of inflammation-related genes in circulating 
monocytes (Padmos et al. 2009).
We also gathered evidence that T cell abnormalities 
play a role in the development of the chronic low grade 
inflammatory state of BD. We detected in four separate 
cohort studies that the T cell system is set at another 
equilibrium in BD and we found mild deficiencies in 
the number of  CD3+ T cells compared to such values 
in healthy controls (HC) (Drexhage et  al. 2011; Snijders 
et  al. 2016; Bergink 2014; Vogels et  al. 2017). Within 
the mildly deficient  CD3+ T cell population there were 
abnormal fluctuations over time in the circulating levels 
of  CD4+ T regulatory (Treg), T helper 2 (Th2), T helper 1 
(Th1) and T helper 17 (Th17) cells. (Drexhage et al. 2011; 
Snijders et  al. 2016; Bergink 2014; Vogels et  al. 2017). 
Mild deficiencies in the percentages of Treg cells cor-
related to raised levels of inflammation-related genes in 
circulating monocytes (Snijders et al. 2016). Breunis et al. 
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(2003) reported higher percentages of activated  CD3+ T 
cells within overall reduced percentages of  CD3+ T cells 
in BD patients as compared to HC, particularly in manic 
patients (Breunis et al. 2003). Wieck et al. (2013) and Bar-
bosa et  al. (2014) reported reduced percentages of Treg 
cells emerging against a background of abnormal circu-
lating levels of Th1, Th2 and Th17 cells in BD patients 
when compared to HC (Wieck et al. 2013; Barbosa et al. 
2014).
All together, these findings suggest the existence of 
a mild deficiency of  CD3+ T cells in at least part of BD 
patients with fluctuating numbers of pro-and anti-
inflammatory T cell subsets over the course of the dis-
ease, influencing a state of low grade inflammation in 
these patients.
Twin studies are suitable to differentiate whether these 
mild T cell deficiencies are due to genetic or (shared/
unique) environmental factors. Therefore, we quantified-
using FACS analysis and a bivariate liability threshold 
twin model-common and unique environmental contri-
butions to the association between BD liability and cir-
culating levels of T cells and T helper cell subsets. Using 
FACS we were also able to investigate the effect of other 
circulating leukocyte subsets playing a role in cell-medi-
ated immunity and described to be abnormal in BD, such 
as the monocytes and natural killer (NK) cells.
Methods
Patients and procedures
The described (bipolar) twins herein belong to the longi-
tudinal Dutch bipolar twin study of the University Medi-
cal Center Utrecht (UMCU). Study design, recruitment 
procedure and study population have been described in 
detail elsewhere (Vonk et  al. 2007; van der Schot et  al. 
2009). Numbers and details on the included twins are 
given in Table 1. Addressing the aim of this study, addi-
tional analysis has been performed regarding mood state. 
Current mood states were assessed using the Young 
Mania Rating Scale (YMRS) (Young et al. 1978) and the 
Inventory for Depressive Symptomatology (IDS) (Rusha 
et  al. 1996). At time of the study, 11 patients were in a 
mood episode, defined as YMRS > 13 and/or IDS > 7, and 
17 were euthymic, defined as YMRS ≤ 13 and/or IDS ≤ 7. 
46% of cases had missing values for current mood state, 
these cases were not included in the analysis. This study 
received approval by the Medical Ethics Committee of 
UMCU. Written informed consent was obtained from all 
participants after a complete description of the study was 
given.
Blood collection, leukocyte preparation and the Fluo-
rescence Activating Cell Sorting (FACS) analysis have 
been described in detail before (Bergink 2014; Snijders 
et al. 2016; Vogels et al. 2017).
Statistical analysis
Genetic modelling was carried out using the OpenMx 
package (Kenny et  al. 2009) in R statistical software. A 
bivariate liability threshold model was used to model the 
data. The variance of a certain trait (such as lymphoid 
subsets) or the covariance between two traits (lymphoid 
subset and the liability to develop BD) can be due to addi-
tive genetic (A); common environment (C), and unique 
environmental factors (E). Twin models focus on the 
difference in resemblance for a trait between monozy-
gotic (MZ) twins who share (nearly) 100% of their genes 
relative to dizygotic (DZ) twin pairs who share on aver-
age 50% of their segregating genes. This means that the 
additive genetic effects acting on members of MZ pairs 
correlate fully (correlation 1), whereas DZ correlation is 
0.5. For both MZ and DZ twins, shared environment fac-
tors are fully correlated by definition. The model does not 
assume correlations between unique environment fac-
tors and these are set to 0. A larger correlation between 
trait(s) in MZ twins than DZ twins indicates that genetic 
factors play a role, but if the MZ correlation is smaller 
than twice the correlation in DZ twins, then shared envi-
ronmental factor are thought to play a role.
To estimate the magnitude effects of A, C and E on 
the different lymphoid subsets a bivariate twin model 
was used. The relative contribution of A, C and E to 
the variance of lymphoid subsets was expressed as 
the percentage of genetic/common environment and 
unique environment in total variance. The univariate 
heritability is calculated with the equation;  h2 = A/
(A + C + E). Common environmental influences 
 (c2) and unique environmental influences  (e2) are 
defined similarly. Disease status was dichotomous and 
assumed to represent an underlying continuous liabil-
ity with a mean of 0 (SD = 1). A bipolar patient will 
have a high value on the liability scale, thereby crossing 
a certain threshold (patient status = 1). All discordant 
co-twins or controls will have lower liability scores and 
will not cross the critical threshold (patient status = 0). 
The bivariate liability threshold twin model elucidate 
genetic, common environmental and unique envi-
ronmental contributions to the association between 
lymphoid subsets and BD liability by investigating 
cross-trait cross-twin correlations. We could not esti-
mate heritability or prevalence from this sample, since 
twin pairs in our sample were specifically selected for 
BD. Therefore, prevalence and heritability of BD were 
fixed to population values (1% prevalence,  h2 = 70%, 
 c2 = 15% and,  e2 = 15%) (Regeer et  al. 2004). Percent-
ages of Th1, Th2, Th17 and Tregs were non-normally 
distributed; therefore the log transformation  (log10) 
was used prior to analysis. As post hoc analyses we 
repeated the genetic modeling including age and sex as 
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covariates. Current lithium use, BMI and smoking sta-
tus were separately included as additional covariates 
(together with age and sex) in bivariate twin models. 
A multivariate analysis of variance (MANOVA) was 
performed to test for overall significant differences 
between different subgroups. Significant MANOVAs 
were post hoc followed by a univariate analysis of vari-
ance (ANOVA). Outliers, defined as 3 standard devia-
tions ≤ or ≥ the mean level) were excluded for further 
analysis.
Results
Significant socio-demographic and clinical differences 
between MZ/DZ and BD/HC twins were not found, 
except for the use of psychotropic medication between 
BD patients and HC (Table 1).
Effect of genes and environmental factors on lymphocyte 
subpopulations
Heritability of the investigated leukocyte subpopulations 
was estimated (Table 2A). The circulating levels of Th17 
and T regulatory cells were predominantly explained by 
genes  (h2: 79 and 69%, respectively), the remaining part 
was largely explained by unique environmental factors 
 (e2: 21 and 28%, respectively).
Half of the variance of the circulating levels of T helper 
2 cells and NK cells was determined by genetic factors 
 (h2: 51% and 50%, respectively), whilst unique and com-
mon environmental factors equally contributed to the 
remaining part of the total variance.
The proportion of total variance in circulating numbers 
of monocytes and T helper 1 cells was mainly determined 
by unique and common environmental factors and only 
for a small part (a quarter) by genetic factors.
Association between the liability to develop bipolar 
disorder and the circulating percentages of T cells and NK 
cells
As shown in Table  2A, of the leukocyte populations 
determined the circulating populations of T cells and NK 
cells showed significant correlations with the phenotype 
BD. These were thus further evaluated.
T cells
A significant negative phenotypic association between 
the liability to develop BD and the percentage of T cells 
was found (rph= − 0.21, p = 0.03). Post-hoc analysis 
showed significantly lower mean levels of percentages 
of T cells in the index and their co-twins as compared to 
the HC twins (p = 0.007) (Table 2B). T cell percentages 
were not significantly different in the group of BD 
patients with an active mood episode versus those in 
euthymic state (50.5% resp. 55.9%,  rs = − 0.31, p = 0.12). 
The covariance of the number of T cells with BD could 
not be attributed to predominant genetic or common 
environmental contributors. Including age and sex as 
covariates did not alter the results (data not shown).
Together with age and sex we corrected for lithium 
treatment, BMI and smoking separately. The pheno-
typic association between the liability to develop BD 
and the circulating levels of T cells lost significance 
after including lithium treatment as confounding factor 
in the bivariate liability threshold model  (rph = − 0.15 
p = 0.107), indicating a role for lithium in this negative 
association. However, also the co-twins of the BD index 
twin without any psychiatric disorder or the co-twins 
of the BD index twin with another psychiatric disorder 
(both not using lithium) showed reduced percentages 
of T cells as compared to the healthy twins, be it only 
statistically significant for the co-twins with another 
psychiatric disorder (52.9 (2.60), respectively 59.0 
(1.17), p = 0.034).
NK cells
The phenotypic association between the liability to 
develop BD and the circulating levels of NK cells also 
reached significance (rph= 0.18, p = 0.04). Post-hoc 
analysis showed significantly higher mean levels of per-
centages of NK cells in the index and co-twins as com-
pared to the HC twins (p = 0.006) (Table 2B). As in the 
case of the percentage of T cells we could not disentan-
gle the covariance between the liability to develop BD 
and levels of circulating NK cells in genetic or environ-
mental covariance. Interestingly enough, in the healthy 
co-twins of the BD index twins significantly higher 
circulating levels of NK cells were found, indicating an 
intrinsic familial liability for higher levels of NK cells 
irrespective of a mood disturbance (data not shown).
Addition of age and sex as covariates did not influ-
ence the results. However, the association between cir-
culating levels of NK cells and the liability to develop 
BD lost some significance after including smoking as 
an additional confounding factor (together with age 
and gender) in the bivariate liability threshold model 
(rph= 0.18, p = 0.06). Correction for BMI and lithium 
did not affect the outcome.
Discussion
By a bivariate twin analysis, we showed that reduced lev-
els of circulating T cells are associated with the liability 
to develop bipolar disorder. Although lithium use was 
associated with reduced circulating levels of T cells in 
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bipolar index cases, we also found that circulating levels 
of T cells were reduced in co-twins without BD not tak-
ing lithium. Neither genetic nor shared or unique envi-
ronmental factors explained the association between 
the decreased circulating levels of T cells and the liabil-
ity to develop BD. This indicates that probably different 
and perhaps varying genetic and environmental factors 
together determine the mild reduction in T cells in the 
families of the twins liable to BD.
Mild deficiencies of T cells per se could explain distur-
bances in mood state, since T cells are indispensable for a 
proper structure and function of the hippocampus (Lewi-
tus et al. 2008; Niebling 2004). Mild to severe T cell defi-
ciencies can be due to genetic defects/polymorphisms, 
such as to the 22q11 deletion syndrome (Vergaelen et al. 
2018). On the other hand environmental influences, such 
as virus infections (e.g. HIV and measles), and nutritional 
deficiencies (e.g. protein) may lead to T cell deficien-
cies. Also stress, related to different states in BD, is 
capable of triggering significant production of inflamma-
tory cytokines (Glaser et al. 2005), which are capable of 
inducing an accelerated T cell apoptosis. Recent findings 
indeed highlight that BD related heritable genetic fac-
tors may act in concert with sustained elevated immune-
inflammatory signaling pathways (Mühleisen et al. 2014).
This study also shows that higher levels of circulating 
NK cells were associated with the liability to develop BD. 
Again neither genetic nor shared or unique environmen-
tal factors significantly explained the association. NK 
cells are considered to be innate immune cells important 
in combating virally infected cells. Raised numbers of 
NK cells would in such view be a sign of a virus infec-
tion. However, NK cells are also capable of dampening 
down the activation of microglial cells (Shi et  al. 2011), 
Table 2 Effect of genes and environmental factors on lymphoid subsets in relation of bipolar disorder
The different lymphoid subsets and NK cells are displayed in order of highest to lowest source of genetic variance
T helper 17 cells:  CD4+ IL17A. T regulatory cells:  CD3+ CD25 highFoxP3+. Total T helper cells:  CD3+  CD4+  CD8−;Total T-cells:  CD3+; T helper 2 cells:  CD4+ IL-4+; NK cells: 
 CD3+–CD56+; Monocytes:  CD14+, T helper 1 cells: CD4+ IFN-y+
Monocytes, T cells, T helper cells and NK cells were expressed in the calculations as percentages of intact  CD45+ PBMC
The subsets of T helper cells (T helper 17, T helper 2, T helper 1 and T regulator cells) were expressed in the calculations as percentages of lymphocytes
* Significant at p = 0.05, uncorrected for multiple comparisons
a To normalize data some values were transformed, for interpretation the means and standard errors were back transformed
b p value based on multivariate analysis (MANOVA). A follow-up univariate analysis with post hoc least significance difference (LSD) analysis was performed for NK 
cells and total T cells
Cell population A. Sources on variance on lymphoid subsets, irrespective of disease 
(n = 106), % (95% CI)
Phenotypic correlation
h2 c2 e2 Rph p
T helper 17 cells 0.79 (0.35–0.88) 0.009 (NA–0.37) 0.21 (0.11–0.38) 0.02 (− 0.17–0.22) 0.80
T regulator cells 0.69 (0.17–0.85) 0.029 (NA–0.39) 0.28 (0.14–0.55) 0.06 (− 0.13–0.25) 0.53
Total T helper cells 0.59 (0.04–0.87) 0.18 (0.00–0.63) 0.22 (0.12–0.42) − 0.06 (−0.25–0.13) 0.54
Total T cells 0.57 (0.00–0.82) 0.11 (0.00–0.57) 0.32 (0.18–0.59) − 0.21 (− 0.38–0.02) 0.03*
T helper 2 cells 0.51 (0.01–0.86) 0.27 (0.00–0.67) 0.22 (0.11–0.47) 0.10 (− 0.09–0.28) 0.30
NK cells 0.50 (0.00–0.82) 0.21 (0.00–0.62) 0.28 (0.14–0.54) 0.18 (0.00–0.34) 0.04*
Monocytes 0.25 (0.09–0.43) 0.30 (0.11–0.51) 0.45 (0.28–0.69) 0.15 (− 0.03–0.32) 0.10
T helper 1 cells 0.19 (0.00–0.74) 0.38 (0.00–0.69) 0.43 (0.24-0.69) − 0.05 (− 0.23–0.13) 0.57
Cell population B. Bipolar twins and their 
co-twins (n = 52)
Healthy control twins (n = 54)
M (S.E.)a M (S.E)a P (MANCOVA/
ANCOVAb)
T helper 17 cells 0.29 (1.07) 0.27 (1.07) 0.349
T regulator cells 1.92 (1.04) 1.83 (1.04) 0.698
Total T helper cells 38.05 (1.18) 38.37 (1.18) 0.402
Total T cells 54.48 (1.18) 59.0 (1.17) 0.015/0.007*
T helper 2 cells 0.68 (1.06) 0.62 (1.6) 0.457
NK cells 12.62 (0.66) 10.01 (0.63) 0.009/0.006*
Monocytes 18.53 (0.81) 16.86 (0.81) 0.181
T helper 1 cells 5.47 (1.07) 5.97 (1.06) 0.553
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and can thus be viewed as a sort of brain-specific “sup-
pressor cells” for pro-inflammatory activated microglial 
cells found in the hippocampus of BD patients (Haarman 
et al. 2015). Moreover, raised numbers of NK cells would 
be capable of suppressing e.g. inflammatory activated 
microglia in the brain.
Our report stands out from other reports, since the 
majority of the reports show normal levels of NK cells 
in BD (Karpiński et al. 2016), including two of our pre-
vious reports (be it that percentages were at the higher 
end of the normal spectrum (Drexhage et  al. 2011; 
Snijders et  al. 2016). It must be noted that, the herein 
found higher circulating level of NK cells just reached 
statistical significance (p = 0.04), and hovered at the 
brink of significance (p = 0.06) after correction for 
smoking. Thus, in sum, the increase in peripheral NK 
cells does not seem to be a strong characteristic of BD.
Limitations
Although our study is one of the largest bipolar twin 
studies, findings are preliminary, and the sample size 
is still too small for a division in relevant subgroups 
(duration of disease, somatic comorbidities, such as 
the metabolic syndrome and cardiovascular disease, 
or medication use) without losing statistical power. 
This probably explains why we could not disentangle 
genetic and environmental influences causing the asso-
ciation between NK, T cells and disease. This not only 
applies to the aforementioned subdivisions, but also to 
other confounding factors influencing immune func-
tions. Several lifestyle (e.g. alcohol, obesogenic diet) 
and environmental factors are known to have effects on 
cell mediated immunity (amongst which is also smok-
ing, which marginally influenced the outcomes for NK 
cells). We also were not sufficiently informed about the 
physical activity and hormonal status (e.g. menstrual 
cycle) of the twins to be able to correct for that.
Furthermore we have not determined the total num-
ber of circulating leukocytes per quantity of blood. We 
have therefore worked with relative percentages, e.g. 
the percentage of T cells of the leukocytes in the col-
lected PBMC preparation. It is more appropriate to 
work with absolute numbers of subsets of leukocytes 
per quantity of blood in future studies.
In summary and despite these limitations, our results 
show that reduced percentages of circulating T cells and 
high percentages of circulating NK cells are linked to the 
liability to develop BD. However confirmation in larger 
cohorts, delivering more detail, is essential. Our results 
make it plausible that the mentioned immune abnormali-
ties are the result of a complex interplay between multi-
ple genetic and environmental risk factors.
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